# Start or STop Anticoagulants Randomised Trial (SoSTART)

Study · id `cardio:ct-nct03153150` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03153150](<https://clinicaltrials.gov/study/NCT03153150>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03153150

Browse, organ or system: Heart; Blood vessels; Brain  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 203 participants.

## Technical summary

Registry record NCT03153150. Randomized; single masking; primary purpose prevention. Start 2018-03-28 (actual); primary completion 2021-03-26 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose prevention
- Phase: Phase 3
- Enrolled: 203 participants (enrolled count; ClinicalTrials.gov record NCT03153150, source copy `cardio:ctgov-nct03153150-2022-04-08`, retrieved 2026-10-26)
- Started: 2018-03-28 (actual) (ClinicalTrials.gov record NCT03153150, source copy `cardio:ctgov-nct03153150-2022-04-08`, retrieved 2026-10-26)
- Primary completion: 2021-03-26 (actual) (ClinicalTrials.gov record NCT03153150, source copy `cardio:ctgov-nct03153150-2022-04-08`, retrieved 2026-10-26)
- Completion: 2021-03-26 (actual) (ClinicalTrials.gov record NCT03153150, source copy `cardio:ctgov-nct03153150-2022-04-08`, retrieved 2026-10-26)
- Countries: United Kingdom (ClinicalTrials.gov record NCT03153150, source copy `cardio:ctgov-nct03153150-2022-04-08`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03153150-2022-04-08`, retrieved 2026-10-26)

## The registry's words

- Brief title: Start or STop Anticoagulants Randomised Trial (SoSTART)
- Acronym: SoSTART
- Condition: Intracranial Hemorrhages
- Condition: Intracranial Hemorrhage, Hypertensive
- Condition: Subarachnoid Hemorrhage
- Condition: Subdural Hematoma
- Condition: Intraventricular Hemorrhage
- Condition: Atrial Fibrillation
- Condition: Atrial Flutter
- Condition: Small Vessel Cerebrovascular Disease
- Condition: Microhaemorrhage
- Intervention (Drug): Apixaban
- Intervention (Drug): Rivaroxaban
- Intervention (Drug): Edoxaban
- Intervention (Drug): Dabigatran
- Intervention (Drug): Acenocoumarol
- Intervention (Drug): Phenindione
- Intervention (Drug): Warfarin
- Lead sponsor: University of Edinburgh
- Lead sponsor class: OTHER
- Collaborator: NHS Lothian
- Collaborator class: OTHER\_GOV

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry condition terms include this condition: Atrial flutter (`cardio:atrial-flutter`)
- Registry condition terms include this condition: Cerebral small vessel disease (`cardio:cerebral-small-vessel-disease`)
- Registry intervention name matches this record: Apixaban (`cardio:apixaban`)
- Registry intervention name matches this record: Rivaroxaban (`cardio:rivaroxaban`)
- Registry intervention name matches this record: Edoxaban (`cardio:edoxaban`)
- Registry intervention name matches this record: Dabigatran (`cardio:dabigatran`)
- Registry intervention name matches this record: Warfarin (`core:warfarin`)
- Registry lists this organization as the lead sponsor: University of Edinburgh (`cardio:org-university-of-edinburgh`)
- Registry lists this organization as a collaborator: NHS Lothian (`cardio:org-nhs-lothian`)

## Provenance

Content hash: 27aaf1b08026b96bc5ca345a3489a2b5d381093228cd35dbec1ee4f68f8494ac
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
